Merrion Pharmaceuticals, Inc. Cuts IPO Price Range to $6-$7 per ADS
Oct 30 (Reuters) - Merrion Pharmaceuticals Plc sharply cut its estimated initial public offering price range to $6 to $7 per American Depositary Share or 4.21 euros and 4.91 euros per ordinary share.